1-(1-(3-甲氧基-4-硝基苯基)哌啶-4-基)-4-甲基哌嗪结构式
|
常用名 | 1-(1-(3-甲氧基-4-硝基苯基)哌啶-4-基)-4-甲基哌嗪 | 英文名 | 1-(1-(3-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-Methylpiperazine |
---|---|---|---|---|
CAS号 | 761440-65-7 | 分子量 | 334.413 | |
密度 | 1.2±0.1 g/cm3 | 沸点 | 488.9±45.0 °C at 760 mmHg | |
分子式 | C17H26N4O3 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 249.5±28.7 °C |
中文名 | 1-(1-(3-甲氧基-4-硝基苯基)哌啶-4-基)-4-甲基哌嗪 |
---|---|
英文名 | 1-[1-(3-Methoxy-4-nitrophenyl)-4-piperidinyl]-4-methylpiperazine |
英文别名 | 更多 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 488.9±45.0 °C at 760 mmHg |
分子式 | C17H26N4O3 |
分子量 | 334.413 |
闪点 | 249.5±28.7 °C |
精确质量 | 334.200500 |
PSA | 64.77000 |
LogP | 1.64 |
蒸汽压 | 0.0±1.2 mmHg at 25°C |
折射率 | 1.576 |
储存条件 | 2-8℃ |
~90% 1-(1-(3-甲氧基-4-硝... 761440-65-7 |
文献:ABBOTT LABORATORIES Patent: US2011/15172 A1, 2011 ; Location in patent: Page/Page column 34 ; |
~89% 1-(1-(3-甲氧基-4-硝... 761440-65-7 |
文献:NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2004/80980 A1, 2004 ; Location in patent: Page 132 ; WO 2004/080980 A1 |
~% 1-(1-(3-甲氧基-4-硝... 761440-65-7 |
文献:Astellas Pharma Inc.; OBITSU, Kazuyoshi; AKIBA, Takahiro; KOBAYASHI, Koji; HIRASAWA, Shun; KONDOH, Yutaka; TAKEGUCHI, Kazuhiro; TAKAHAMA, Yuji; ORII, Ryoki Patent: EP2669281 A1, 2013 ; |
~% 1-(1-(3-甲氧基-4-硝... 761440-65-7 |
文献:Astellas Pharma Inc.; OBITSU, Kazuyoshi; AKIBA, Takahiro; KOBAYASHI, Koji; HIRASAWA, Shun; KONDOH, Yutaka; TAKEGUCHI, Kazuhiro; TAKAHAMA, Yuji; ORII, Ryoki Patent: EP2669281 A1, 2013 ; |
1-[1-(3-Methoxy-4-nitrophenyl)-4-piperidinyl]-4-methylpiperazine |
1-[1-(3-cyano-3,3-diphenyl-propyl)-piperidin-4-yl]-3-propionyl-1,3-dihydro-benzoimidazol-2-one |
Bezitramida [INN-Spanish] |
BEZITRAMIDE |
Piperazine, 1-[1-(3-methoxy-4-nitrophenyl)-4-piperidinyl]-4-methyl- |
Bezitramidum [INN-Latin] |
Burgodin |
1-[1-(3-methoxy-4-nitrophenyl)piperidin-4-yl]-4-methylpiperazine |
benzitramide |